Multiple studies have been performed that examine Akt pathway inhibition in other human cancer types, including one study using a dual inhibitor of PI3K and mTOR in human head and neck cancer that demonstrated both in vitro and in vivo anti-neoplastic effects [40]. This evidence concerns the gene AKT1 and head and neck cancer.